Pancreatic Cancer Research

ResearcherThird Affiliated Hospital of Harbin Medical UniversityActive in the last 2 years

Rui Xie

ORCID-verified (high confidence)As of 11 November 2026

Matched on ORCID iD 0000-0003-0357-6702; OpenAlex author ID A5074683778.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 4

  1. Meaningful nomograms based on systemic immune inflammation index predicted survival in metastatic pancreatic cancer patients receiving chemotherapy. Last author DOI 10.1002/cam4.7453↗
  2. Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma. Last author DOI 10.1186/s12885-023-11042-7↗
  3. 5-Aminolevulinic acid hydrochloride loaded microbubbles-mediated sonodynamic therapy in pancreatic cancer cells. Last author DOI 10.1080/21691401.2020.1813743↗
  4. Sonodynamically induced anti-tumor effect of 5-aminolevulinic acid on pancreatic cancer cells. Co-author DOI 10.1016/j.ultrasmedbio.2014.07.003↗

Closest collaborators

The 7 strongest of 7 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Yanan Sun · 2 shared papers, 2023–2024
  2. Ruitao Wang · 1 shared paper, 2024
  3. Zhichang Ba · 1 shared paper, 2023
  4. Xiaoling Zhang · 1 shared paper, 2023
  5. Wei Yang · 1 shared paper, 2020
  6. Yan Jing Li · 1 shared paper, 2014
  7. Ye Tian · 1 shared paper, 2014

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.